cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2008; 52:1869-1880, doi:10.1016/j.jacc.2008.07.064
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow GENUINE ARTICLE: View Related Genuine Article on CVN
Right arrow View Related Genuine Article on CVN
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Google Scholar
Right arrow Articles by Okada, M.
Right arrow Articles by Huard, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okada, M.
Right arrow Articles by Huard, J.
Related Collections
Right arrowRelated Articles

MINI-FOCUS: CELL-BASED THERAPY

Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium

Masaho Okada, MD*,{ddagger}, Thomas R. Payne, PhD*,{ddagger},||, Bo Zheng, MD*,{ddagger}, Hideki Oshima, MD, PhD*,{ddagger}, Nobuo Momoi, MD{dagger}, Kimimasa Tobita, MD{dagger},||, Bradley B. Keller, MD{dagger}, Julie A. Phillippi, PhD*, Bruno Péault, PhD*,{dagger} and Johnny Huard, PhD*,{ddagger},§,||,*

* Stem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
{dagger} Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
{ddagger} Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
§ Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
|| Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Carnegie Mellon University, Pittsburgh, Pennsylvania

Manuscript received April 21, 2008; revised manuscript received July 16, 2008, accepted July 21, 2008.

* Reprint requests and correspondence: Dr. Johnny Huard, Stem Cell Research Center, 4100 Rangos Research Center, 3460 Fifth Avenue, Pittsburgh, Pennsylvania 15213 (Email: jhuard{at}pitt.edu).

Objectives: The aim of this study was to evaluate the therapeutic potential of human skeletal muscle-derived myoendothelial cells for myocardial infarct repair.

Background: We have recently identified and purified a novel population of myoendothelial cells from human skeletal muscle. These cells coexpress myogenic and endothelial cell markers and produce robust muscle regeneration when injected into cardiotoxin-injured skeletal muscle.

Methods: Myoendothelial cells were isolated from biopsies of human skeletal muscle using a fluorescence-activated cell sorter along with populations of regular myoblasts and endothelial cells. Acute myocardial infarction was induced in male immune-deficient mice, and cells were directly injected into the ischemic area. Cardiac function was assessed by echocardiography, and donor cell engraftment, angiogenesis, scar tissue, endogenous cardiomyocyte proliferation, and apoptosis were all evaluated by immunohistochemistry.

Results: A greater improvement in left ventricular function was observed after intramyocardial injection of myoendothelial cells when compared with that seen in hearts injected with myoblast or endothelial cells. Transplanted myoendothelial cells generated robust engraftments within the infarcted myocardium, and also stimulated angiogenesis, attenuation of scar tissue, and proliferation and survival of endogenous cardiomyocytes more effectively than transplanted myoblasts or endothelial cells.

Conclusions: Our findings suggest that myoendothelial cells represent a novel cell population from human skeletal muscle that may hold promise for cardiac repair.

Key Words: human stem cells • myocardial infarction • paracrine factors • skeletal muscle • VEGF

Abbreviations and Acronyms
  cTnI = cardiac-specific isoforms of troponin I
  cTnT = cardiac-specific isoforms of troponin T
  DMEM = Dulbecco's modified Eagle's medium
  EDA = end-diastolic area
  ELISA = enzyme-linked immunoadsorbent assay
  FAC = fractional area change
  FACS = fluorescence-activated cell sorting
  FBS = fetal bovine serum
  fskMyHC = fast skeletal myosin heavy chain
  LV = left ventricle/ventricular
  MDSC = muscle-derived stem cell
  MI = myocardial infarction
  nLacZ = nuclear LacZ
  PBS = phosphate-buffered saline
  PCNA = proliferating cell nuclear antigen
  qPCR = quantitative real-time polymerase chain reaction
  SkM = skeletal myoblast
  TUNEL = terminal dUPT nick end-labeling
  VEGF = vascular endothelial growth factor


Related Articles

Skeletal Myoblasts for Cardiac Repair: Act II?
Philippe Menasché
J. Am. Coll. Cardiol. 2008 52: 1881-1883. [Full Text] [PDF]

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A40. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
P. Menasche
Skeletal Myoblasts for Cardiac Repair: Act II?
J. Am. Coll. Cardiol., December 2, 2008; 52(23): 1881 - 1883.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home